Leukine (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Leukine drug offered from sanofi-aventis U.S. LLC. This Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | SARGRAMOSTIM |
SUBSTANCE NAME: | SARGRAMOSTIM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1996-12-01 |
END MARKETING DATE: | 0000-00-00 |
Leukine HUMAN PRESCRIPTION DRUG Details:
Item Description | Leukine from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(ug/mL) |
START MARKETING DATE: | 1996-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0024-5844_aca63889-1042-411c-8cc1-f4d5c0ee4f44 |
PRODUCT NDC: | 0024-5844 |
APPLICATION NUMBER: | BLA103362 |
Other SARGRAMOSTIM Pharmaceutical Manufacturers / Labelers: